Animalcare reports a ‘positive’ trading environment
MASHAM-based Animalcare is continuing to experience a “positive” trading environment across the group with profits on the rise.
The North Yorkshire firm, which is one of the UK’s leading suppliers of veterinary medicines and animal identification products, said today that results for the year ended June 30 are expected to meet market expectations.
In March the group, which changed its name from Ritchey to Animalcare after the reverse takeover of the former Genus subsidiary, reported a move into profit after restructuring the business.
Turnover grew to £7.76m from £3.41m for the half year ended December 31, 2008. Like-for-like pre-tax profit was £900,000 compared to a £10,000 loss.
Animalcare said that its performance had been boosted by two recently introduced generic veterinary medicines – Buprecare and Benzacare, the latter of which has been approved for the treatment of renal failure in cats.
Additionally, it has been granted marketing authorisations in the UK and other European markets for Cephacare, a generic version of the antibiotic Cephalexin for the treatment of skin conditions in dogs and cats.
The Ritchey livestock business delivered revenue of £3.4m in line with the same period in 2007, achieving modest growth offset by the change to trading arrangements with a major supplier.
